Web7 feb. 2024 · This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) before surgery [neoadjuvant phase], followed by pembrolizumab alone after surgery [adjuvant phase] in participants with resectable stage II, IIIA, and resectable IIIB (T3-4N2) non-small cell lung … Web1 jun. 2024 · KEYNOTE-671 (NCT03425643) is a phase 3 study that evaluates standard neoadjuvant chemotherapy with perioperative pembrolizumab or placebo in early-stage NSCLC. Methods: This international double-blind phase 3 trial enrolls patients aged ≥18 years with previously untreated, resectable stage IIB/IIIA NSCLC, ECOG PS 0–1, and …
Pembrolizumab for Persistent, Recurrent, or Metastatic …
Web8 mei 2013 · Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) The safety and scientific validity of this study is … Web1 okt. 2024 · After the KEYNOTE-158 study, in which pembrolizumab showed durable antitumor activity, pembrolizumab monotherapy was approved for patients with PD … onedrive handy bilder automatisch hochladen
KEYNOTE-975 study design: a Phase III study of definitive ... - PubMed
Web15 feb. 2011 · Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) (KEYNOTE-001) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Web8 jun. 2024 · The aim of the randomized, double-blind, Phase III KEYNOTE-921 study is to evaluate the efficacy and safety of pembrolizumab plus docetaxel in patients with … WebKEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma Future Oncol. 2024 Apr;17(10):1143-1153. doi: 10.2217/fon-2024-0969. ... Clinical trial registration: NCT04210115 (ClinicalTrials.gov). is barnard college all female